Clinical Trial Update: Changes in Body Composition After EPA Supplementation in Head and Neck Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on EPA supplementation showing changes in body composition in head and neck cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• EPA supplementation (eicosapentaenoic acid)

Snippet

Sponsor: Institut Català d'Oncologia | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 3 | Status: COMPLETED